Letter: Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.

Mechanism of local skin atrophy caused by intradermally injected corticosteroids.

Immune response of infants to inactivated poliovirus vaccine injected intradermally.

$Injected corticosteroids in refractory asthma.$
Injected corticosteroids in refractory asthma.

$Injected corticosteroids in refractory asthma.$
Injected corticosteroids in refractory asthma.

Immune response to intradermally injected inactivated poliovirus vaccine.

Pathological changes in calves injected intradermally with Mycobacterium intracellulare serotype Davis and M. avium serotype 2.

Letter: Withdrawal of corticosteroids.

Letter: Withdrawal of corticosteroids.

Letter: Corticosteroids, salbutamol, and R.D.S.

Letter: Fluorinated corticosteroids and dermatophytosis.

Inhaled corticosteroids: potency, dose equivalence and therapeutic index.

Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.

Prepartion of 16alpha-alkoxy and 16alpha-acyloxy derivatives of 21-chloro-17-acyloxy corticosteroids and determination of their vasoconstrictor activities in humans.

Letter: Corticosteroids in treatment of anaphylaxis.

Letter: Splenic atrophy and thyrotoxicosis.

Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally.

Letter: Prostaglandins and the pulmonary vasoconstrictor response to alveolar hypoxia.

Clinical trials of topical corticosteroids in psoriasis: correlations with the vasoconstrictor assay.

Letter: Corticosteroids contained in Mexican cures for arthritis and asthma.

Human gastrin-releasing peptide: biological potency in humans.

Letter: Perilymphatic atrophy of the skin.

First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids.

Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure.

Properties and therapeutic uses of some corticosteroids with enhanced topical potency.

Suggest Documents

Mechanism of local skin atrophy caused by intradermally injected corticosteroids.

Immune response of infants to inactivated poliovirus vaccine injected intradermally.

Injected corticosteroids in refractory asthma.

Injected corticosteroids in refractory asthma.

Immune response to intradermally injected inactivated poliovirus vaccine.

Pathological changes in calves injected intradermally with Mycobacterium intracellulare serotype Davis and M. avium serotype 2.

Letter: Withdrawal of corticosteroids.

Letter: Withdrawal of corticosteroids.

Letter: Corticosteroids, salbutamol, and R.D.S.

Letter: Fluorinated corticosteroids and dermatophytosis.

Inhaled corticosteroids: potency, dose equivalence and therapeutic index.

Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.

Prepartion of 16alpha-alkoxy and 16alpha-acyloxy derivatives of 21-chloro-17-acyloxy corticosteroids and determination of their vasoconstrictor activities in humans.

Letter: Corticosteroids in treatment of anaphylaxis.

Letter: Splenic atrophy and thyrotoxicosis.

Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally.

Letter: Prostaglandins and the pulmonary vasoconstrictor response to alveolar hypoxia.

Clinical trials of topical corticosteroids in psoriasis: correlations with the vasoconstrictor assay.

Letter: Corticosteroids contained in Mexican cures for arthritis and asthma.

Human gastrin-releasing peptide: biological potency in humans.

Letter: Perilymphatic atrophy of the skin.

First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids.

Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure.

Properties and therapeutic uses of some corticosteroids with enhanced topical potency.

Letter: Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.

Recommend Documents

Follow Us